Chunhai Charlie Hao

Degrome Therapeutics, Inc.

NIH Rank #16149
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$945.6K
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#16,149
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $945.6K across 2 grants · National rank #16149.

Top grants by award amount

Chunhai Charlie Hao's NIH grant portfolio, ranked by award amount.

  • 1R41AG090241-01R41
    Development of Small-Molecule Degraders of APP as the first-in-class drugs for Alzheimer's therapy
    $499.9K
    award amount
  • 5R01NS126358-03R01
    Development of BBB-permeable SUMO1 small molecule degraders for glioblastoma therapy.
    $445.7K
    award amount

Affiliations

Institutions that have administered grants for Chunhai Charlie Hao.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Degrome Therapeutics, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    Multi-Institutional Research
    Awards at 2 institutions